• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Emmessar Biotech & Nutrition Ltd — Board Meeting, 11-02-2026: Board Meeting

    11-02-2026 | 02:14 pm

    Emmessar Biotech's board approved Q3 FY25 financial results. Revenue from operations was ₹1.02 Cr, with a net loss of ₹0.18 Cr for the quarter. The company reported a loss of ₹0.33 Cr for the nine-month period.

    No comments yet. Be the first to comment!

    All announcements from Emmessar Biotech & Nutrition Ltd